A citation-based method for searching scientific literature

Kavita Singh, Dhananjay Yadav, Meenu Jain, Pramod Kumar Singh, Jun-O Jin. Endocr Metab Immune Disord Drug Targets 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Expression of Tim-3 in breast cancer tissue promotes tumor progression.
Shiqing Cheng, Fuyan Han, Yanqiu Xu, Teng Qu, Ying Ju. Int J Clin Exp Pathol 2018
7
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Significance of TIM-3 expression by CD4+ and CD8+ T lymphocytes in tumor-draining lymph nodes from patients with breast cancer.
Sahar Shariati, Atri Ghods, Mahshid Zohouri, Reza Rasolmali, Abdol-Rasoul Talei, Fereshteh Mehdipour, Abbas Ghaderi. Mol Immunol 2020
4
100

Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+ CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer.
Hongling Liang, Hongsheng Li, Zhi Xie, Tianen Jin, Yu Chen, Zhiyi Lv, Xiaojun Tan, Jia Li, Guodong Han, Weixing He,[...]. Thorac Cancer 2020
5
100

Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells.
Miriam Victoria Martín-Manzo, Carlos Lara, Cruz Vargas-de-Leon, Julio Carrero, Gloria Queipo, Miguel Fonseca-Sanchez, Nancy R Mejia-Dominguez, David Kershenobich, Srinivas Mummidi, Alejandro Zentella-Dehesa,[...]. Pathol Oncol Res 2019
13
100

T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.
Wenjing Yi, Peixin Zhang, Yan Liang, Yun Zhou, Huanjun Shen, Chao Fan, Jonathan P Moorman, Zhi Q Yao, Zhansheng Jia, Ying Zhang. Immunology 2017
12
100

Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives.
L de la Cruz-Merino, M Chiesa, R Caballero, F Rojo, N Palazón, F H Carrasco, V Sánchez-Margalet. Int Rev Cell Mol Biol 2017
29
100

Prognostic value of immune checkpoint molecules in breast cancer.
Jun Fang, Feng Chen, Dong Liu, Feiying Gu, Zhigang Chen, Yuezhen Wang. Biosci Rep 2020
29
100


TIM-3 Regulates Distinct Functions in Macrophages.
Ranferi Ocaña-Guzman, Luis Torre-Bouscoulet, Isabel Sada-Ovalle. Front Immunol 2016
68
100


Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
Leisha A Emens, Cristina Cruz, Joseph Paul Eder, Fadi Braiteh, Cathie Chung, Sara M Tolaney, Irene Kuter, Rita Nanda, Philippe A Cassier, Jean-Pierre Delord,[...]. JAMA Oncol 2019
348
100

IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Elise K Heon, Hasi Wulan, Loch P Macdonald, Adel O Malek, Glenn H Braunstein, Connie G Eaves, Mark D Schattner, Peter M Allen, Michael O Alexander, Cynthia A Hawkins,[...]. Biochem Biophys Res Commun 2015
12
100

The regulation of TIM-3 transcription in T cells involves c-Jun binding but not CpG methylation at the TIM-3 promoter.
Su Jin Yun, Ka-Jung Jun, Kuniharu Komori, Mi Jin Lee, Myung-Hee Kwon, Yong-Joon Chwae, Kyongmin Kim, Ho-Joon Shin, Sun Park. Mol Immunol 2016
7
100

Corrigendum: Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping.
Jiyan Su, Dan Li, Qianjun Chen, Muxia Li, Lu Su, Ting Luo, Danling Liang, Guoxiao Lai, Ou Shuai, Chunwei Jiao,[...]. Front Microbiol 2019
3
100

Expansion of CD11b+Ly-6C+ myeloid-derived suppressor cells (MDSCs) driven by galectin-9 attenuates CVB3-induced myocarditis.
Yingying Zhang, Mengying Zhang, Xueqin Li, Zongsheng Tang, Ling He, Kun Lv. Mol Immunol 2017
12
100

Tim-3 identifies exhausted follicular helper T cells in breast cancer patients.
Shiguang Zhu, Jun Lin, Guangdong Qiao, Xingmiao Wang, Yanping Xu. Immunobiology 2016
28
100

T-bet, a Th1 transcription factor regulates the expression of Tim-3.
Ana C Anderson, Graham M Lord, Valerie Dardalhon, David H Lee, Catherine A Sabatos-Peyton, Laurie H Glimcher, Vijay K Kuchroo. Eur J Immunol 2010
81
100

A seven-nuclear receptor-based prognostic signature in breast cancer.
F Wu, W Chen, X Kang, L Jin, J Bai, H Zhang, X Zhang. Clin Transl Oncol 2021
4
100

Single nucleotide polymorphisms and cancer susceptibility.
Na Deng, Heng Zhou, Hua Fan, Yuan Yuan. Oncotarget 2017
107
100

CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Yu-Hwa Huang, Chen Zhu, Yasuyuki Kondo, Ana C Anderson, Amit Gandhi, Andrew Russell, Stephanie K Dougan, Britt-Sabina Petersen, Espen Melum, Thomas Pertel,[...]. Nature 2015
346
100

TIM3 comes of age as an inhibitory receptor.
Yochai Wolf, Ana C Anderson, Vijay K Kuchroo. Nat Rev Immunol 2020
248
100

DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients.
Asma A Elashi, Varun Sasidharan Nair, Rowaida Z Taha, Hibah Shaath, Eyad Elkord. Oncoimmunology 2018
31
100

Activation of mitogen activated protein kinase-Erk kinase (MEK) increases T cell immunoglobulin mucin domain-3 (TIM-3) transcription in human T lymphocytes and a human mast cell line.
Soo-Jin Yoon, Mi Jin Lee, Dong-Chul Shin, Jung Sik Kim, Yong-Joon Chwae, Myung-Hee Kwon, Kyongmin Kim, Sun Park. Mol Immunol 2011
14
100

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.
Pradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, Sujita Sukumaran, Norihiro Watanabe, Valentina Hoyos, Premal Lulla, Malcolm K Brenner, Ann M Leen, Juan F Vera. J Immunother Cancer 2018
56
100

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.
Shuang Qin, Linping Xu, Ming Yi, Shengnan Yu, Kongming Wu, Suxia Luo. Mol Cancer 2019
379
100

Tim-3 expression in cervical cancer promotes tumor metastasis.
Yang Cao, Xiaoxi Zhou, Xiaoyuan Huang, Qinlu Li, Lili Gao, Lijun Jiang, Mei Huang, Jianfeng Zhou. PLoS One 2013
92
100

Not All Immune Checkpoints Are Created Equal.
Annika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer, Peter Steinberger. Front Immunol 2018
80
100

Emerging role of RNA modification N6-methyladenosine in immune evasion.
Xin Lou, Juan-Juan Wang, Ya-Qing Wei, Jin-Jin Sun. Cell Death Dis 2021
18
100


Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
100

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.
Ming Yi, Jing Zhang, Anping Li, Mengke Niu, Yongxiang Yan, Ying Jiao, Suxia Luo, Pengfei Zhou, Kongming Wu. J Hematol Oncol 2021
34
100

The role of STAT3 in leading the crosstalk between human cancers and the immune system.
Yu Wang, Yicheng Shen, Sinan Wang, Qiang Shen, Xuan Zhou. Cancer Lett 2018
150
100

Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.
Zheng Wang, Xinghan Liu, Xijing Wang, Tie Chong, Shuai Lin, Meng Wang, Xiaobin Ma, Kang Liu, Peng Xu, Yanjing Feng,[...]. Oncotarget 2016
17
100

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status.
Junlong Wu, Guowen Lin, Yao Zhu, Hailiang Zhang, Guohai Shi, Yijun Shen, Yiping Zhu, Bo Dai, Dingwei Ye. Sci Rep 2017
30
100

Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC.
Xuewei Zhuang, Xiaoning Zhang, Xiyan Xia, Cuijuan Zhang, Xiaohong Liang, Lifen Gao, Xin Zhang, Chunhong Ma. Am J Clin Pathol 2012
66
100

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
Laurent Monney, Catherine A Sabatos, Jason L Gaglia, Akemi Ryu, Hanspeter Waldner, Tatyana Chernova, Stephen Manning, Edward A Greenfield, Anthony J Coyle, Raymond A Sobel,[...]. Nature 2002
100

miR-149-3p reverses CD8+ T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells.
Meng Zhang, Dian Gao, Yanmei Shi, Yifan Wang, Rakesh Joshi, Qiongfang Yu, Daheng Liu, Faizah Alotaibi, Yujuan Zhang, Hongmei Wang,[...]. Open Biol 2019
20
100


Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer.
Lieze Berben, Giuseppe Floris, Cindy Kenis, Bruna Dalmasso, Ann Smeets, Hanne Vos, Patrick Neven, Asier Antoranz Martinez, Annouschka Laenen, Hans Wildiers,[...]. Clin Transl Immunology 2020
15
100

CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.
Ha Zhu, Yan Gu, Yiquan Xue, Ming Yuan, Xuetao Cao, Qiuyan Liu. Oncotarget 2017
57
100



T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer.
Kyung Do Byun, Hyo Jun Hwang, Ki Jae Park, Min Chan Kim, Se Heon Cho, Mi Ha Ju, Jin Hwa Lee, Jin Sook Jeong. J Breast Cancer 2018
23
100

T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Meng Yang, Qinchao Yu, Jing Liu, Weiwei Fu, Yanwei Cao, Lun Yu, Shixiu Shao, Xinsheng Wang, Haitao Niu, Yonghua Wang. J Surg Oncol 2015
43
100

Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients.
Jieqiong Liu, Ying Li, Qian Li, Dandan Liang, Quanren Wang, Qiang Liu. Breast Cancer Res Treat 2021
8
100

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study.
Victor Sarradin, Amélie Lusque, Thomas Filleron, Florence Dalenc, Camille Franchet. Breast Cancer Res 2021
2
100

M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.
Karin M Knudson, Kristin C Hicks, Xiaoling Luo, Jin-Qiu Chen, Jeffrey Schlom, Sofia R Gameiro. Oncoimmunology 2018
111
100

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients.
Dae-Won Lee, Han Suk Ryu, Min-Sun Jin, Kyung-Hun Lee, Koung Jin Suh, Jeonghwan Youk, Jung Youn Kim, Ahrum Min, Han-Byoel Lee, Hyeong-Gon Moon,[...]. Br J Cancer 2019
8
100

TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.
Yang Zhang, Pengcheng Cai, Tao Liang, Lin Wang, Lihua Hu. Oncotarget 2017
45
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.